Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE920
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,420
Award facts
- Contract value 100% obligated
- $52,420.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $52,420.45 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, which is not set-aside, is expected to be completed by January 13, 2026, with performance occurring at the awardee's Conshohocken facility. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), which serves as the parent entity. The delivery order draws from Cencora's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, which functions as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
This delivery order represents a task under the broader Pharmaceutical Prime Vendor program, through which DLA procures an extensive range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, syringes, and specialized medical commodities to support military treatment facilities and other federal healthcare systems worldwide. The Defense Logistics Agency's Medical Supply Chain relies on this vendor's capability to efficiently fulfill orders across multiple therapeutic domains on a competitive, full and open basis. Amerisourcebergen's track record of successful federal pharmaceutical procurement, demonstrated through numerous prior awards ranging in value from minimal amounts to substantial orders exceeding $45,000, underscores the contractor's qualification to deliver critical medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DU26FE920?
SPE2DU26FE920 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FE920 worth?
The government has obligated $52,420 on SPE2DU26FE920.
Is contract SPE2DU26FE920 an order under another contract?
Yes. SPE2DU26FE920 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE920 competed?
The extent of competition for SPE2DU26FE920 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award